TY - JOUR
T1 - TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome
AU - GenTAC Registry Investigators
AU - Corbitt, Holly
AU - Morris, Shaine A.
AU - Gravholt, Claus H.
AU - Mortensen, Kristian H.
AU - Tippner-Hedges, Rebecca
AU - Silberbach, Michael
AU - Maslen, Cheryl L.
N1 - Funding Information:
The GenTAC Registry was supported by US Federal Government contracts HHSN268200648199C and HHSN268201000048C from the National Heart Lung and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD). Whole exome sequencing services were provided by the University of Washington, Department of Genome Sciences under U.S. Federal Government contract number, US Federal Government contract number HHSN268201100037C (to D. Nickerson). This work is supported in part by the Ravelle Family Fund of the Turner Syndrome Society of the United States (MS). HC receives support from The Friends of Doernbecher Foundation and The American Heart Association Western States Affiliate grant number 16PRE30190012. SAM is supported by NHLBI grant K23HL127266. CLM receives support from the OHSU School of Medicine, and the Knight Cardiovascular Institute at Oregon Health & Science University. The Danish replication cohort development was supported by grants from the Lundbeck Foundation, the Augustinus Foundation, The Toyota Foundation, the Aase og Einar Danielsen Foundation, the Novo Nordisk Foundation (NNF13OC0003234, NNF15OC0016474).
Publisher Copyright:
© 2018 Corbitt et al. http://creativecommons.org/licenses/by/4.0/.
PY - 2018/10
Y1 - 2018/10
N2 - Turner syndrome is caused by complete or partial loss of the second sex chromosome, occurring in ~1 in 2,000 female births. There is a greatly increased incidence of aortopathy of unknown etiology, including bicuspid aortic valve (BAV), thoracic aortic aneurysms, aortic dissection and rupture. We performed whole exome sequencing on 188 Turner syndrome participants from the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Related Conditions (GenTAC). A gene-based burden test, the optimal sequence kernel association test (SKAT-O), was used to evaluate the data with BAV and aortic dimension z-scores as covariates. Genes on chromosome Xp were analyzed for the potential to contribute to aortopathy when hemizygous. Exome analysis revealed that TIMP3 was associated with indices of aortopathy at exome-wide significance (p = 2.27 x 10−7), which was replicated in a separate cohort. The analysis of Xp genes revealed that TIMP1, which is a functionally redundant paralogue of TIMP3, was hemizygous in >50% of our discovery cohort and that having only one copy of TIMP1 increased the odds of having aortopathy (OR = 9.76, 95% CI = 1.91–178.80, p = 0.029). The combinatorial effect of a single copy of TIMP1 and TIMP3 risk alleles further increased the risk for aortopathy (OR = 12.86, 95% CI = 2.57–99.39, p = 0.004). The products of genes encoding tissue inhibitors of matrix metalloproteinases (TIMPs) are involved in development of the aortic valve and protect tissue integrity of the aorta. We propose that the combination of X chromosome TIMP1 hemizygosity and variants of its autosomal paralogue TIMP3, significantly increases the risk of aortopathy in Turner syndrome.
AB - Turner syndrome is caused by complete or partial loss of the second sex chromosome, occurring in ~1 in 2,000 female births. There is a greatly increased incidence of aortopathy of unknown etiology, including bicuspid aortic valve (BAV), thoracic aortic aneurysms, aortic dissection and rupture. We performed whole exome sequencing on 188 Turner syndrome participants from the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Related Conditions (GenTAC). A gene-based burden test, the optimal sequence kernel association test (SKAT-O), was used to evaluate the data with BAV and aortic dimension z-scores as covariates. Genes on chromosome Xp were analyzed for the potential to contribute to aortopathy when hemizygous. Exome analysis revealed that TIMP3 was associated with indices of aortopathy at exome-wide significance (p = 2.27 x 10−7), which was replicated in a separate cohort. The analysis of Xp genes revealed that TIMP1, which is a functionally redundant paralogue of TIMP3, was hemizygous in >50% of our discovery cohort and that having only one copy of TIMP1 increased the odds of having aortopathy (OR = 9.76, 95% CI = 1.91–178.80, p = 0.029). The combinatorial effect of a single copy of TIMP1 and TIMP3 risk alleles further increased the risk for aortopathy (OR = 12.86, 95% CI = 2.57–99.39, p = 0.004). The products of genes encoding tissue inhibitors of matrix metalloproteinases (TIMPs) are involved in development of the aortic valve and protect tissue integrity of the aorta. We propose that the combination of X chromosome TIMP1 hemizygosity and variants of its autosomal paralogue TIMP3, significantly increases the risk of aortopathy in Turner syndrome.
UR - http://www.scopus.com/inward/record.url?scp=85055075571&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055075571&partnerID=8YFLogxK
U2 - 10.1371/journal.pgen.1007692
DO - 10.1371/journal.pgen.1007692
M3 - Article
C2 - 30281655
AN - SCOPUS:85055075571
SN - 1553-7390
VL - 14
JO - PLoS Genetics
JF - PLoS Genetics
IS - 10
M1 - e1007692
ER -